I actually pulled that up yesterday. The ask was heavy so I looked away.

I was never good at playing 000 stocks.

Beauty!

CFGN on high bid. I don't think he had any to sell when he did on the ask.

Oops?

ABCE 26M float. Helloooo!

Took more. No brainer.

I want more at .01ish.

ABCE I've decided to accumulate more shares. Will be watching closely.

.02+ today is very possible.

ABCE 8K. So refreshing..


Effective as of January 31, 2019, ABCO Energy, Inc [“Company”] acquired through redemption from Redstart Holdings Corp, [“RHC”] 68,000 shares of the Series C Preferred Stock [“Redeemed Preferred Shares”] owned by RHC.. The redemption price for the Redeemed Preferred Shares was $101,810.55 which was financed through a cash advance transaction of future receivables.

ABCE float only 26M per this..

https://investorshub.advfn.com/boards/replies.aspx?msg=146558942

ABCE Only 35M O/S. That's nutty.

.0095. Penny break coming.

Good to see you. Looks like ez money to me.

Their market cap is nothing down here.

.0083 up. Gonna surprise folks soon imo.

.085

ABCE .0075. Really like this one after reading their last PR.

O/S is only 35M

Check out their revenue. Also it looks like more news is coming soon. Recently came off a RS. I think some leftovers from CDEL are still hitting. I'm in now while it's easier to get shares.

ABCO Energy Pays Off Convertible Debt, Plans Retirement of RemainderPress Release | 01/31/2019

https://www.otcmarkets.com/stock/ABCE/news/ABCO-Energy-Pays-Off-Convertible-Debt-Plans-Retirement-of-Remainder?id=217136

Ty, OTCX finally finished.

I guess that went right over your head hooker.

Have a nice day!

At some point, there will be no comedy allowed.

Should we now ban the movie space balls?

After all, this was in it

Sick SOB! https://www.vox.com/2019/2/1/18205428/virginia-abortion-bill-kathy-tran-ralph-northam

Northams past as dressing up as a black person or a kkk member doesnt offend me as I see it as attempt to be comical, they are having a beer together.

His stance on an outrageous abortion law offends me and should offend everyone. Talk about crossing the line, that is one sick fucker. That should be the reason he should step down.

The dems got an 'out' when that pic was found.

Nope, took a loss on it.

Sure does, hoping IRNC will go soon too.

Hard to say but he's not selling aggressively and he did come up on the bid side so I'd guess that he doesnt have much left. He also moved up from yesterday on the ask.

I wish I knew for sure.

IRNC OTCX moved to high bid, may be finishing here.

Keep an eye on it.

.002

VCII check out L2 ask side. 3.2M float.

IRNC .045 ask. Check out the last PRs. Pretty cool company imo.

The chart appears to be turning now.

https://www.stockscores.com/charts/charts/?ticker=Irnc

IronClad Encryption Receives Allowance for Six Patents from USPTO
Press Release | 11/07/2018
https://www.otcmarkets.com/stock/IRNC/news/IronClad-Encryption-Receives-Allowance-for-Six-Patents-from-USPTO?id=209450


Layer 3 Communications Validates IronClad Encryption’s Cyber Security Technology
Press Release | 10/17/2018
https://www.otcmarkets.com/stock/IRNC/news/Layer-3-Communications-Validates-IronClad-Encryptions-Cyber-Security-Technology?id=207215

DoD Contractor Charter Trading to Implement IronClad’s ICEmicro for International Security
Press Release | 09/25/2018
https://www.otcmarkets.com/stock/IRNC/news/DoD-Contractor-Charter-Trading-to-Implement-IronClads-ICEmicro-for-International-Security?id=204802

.0017

Insane mover.

IRNC took some at .04. Check the SS, chart and company out.

Donno, I'm mainly playing the bounce. Just saw that on their website.

ONCX We are developing Prolanta™, a targeted therapeutic protein for the treatment of ovarian, breast and other cancers. The Company has a US FDA-cleared IND to commence human testing of Prolanta™ in our first indication, the treatment of ovarian cancer. This clinical trial began in 2016. Preliminary data from the first dosing group (the low dose) of this trial suggest Prolanta is safe with some evidence of efficacy in a patient population that is difficult to treat. Prolanta™ is a prolactin receptor antagonist that has demonstrated significant efficacy in xenograft models through a unique mechanism of action, autophagy (see Our Science). In addition to ovarian cancer, there is strong preclinical evidence Prolanta™ will be effective in breast, prostate and other cancers.

The FDA has also approved the designation of Prolanta™ as an Orphan Drug for the treatment of ovarian cancer, which may allow reduced filing fees, federal tax credits and marketing exclusivity by the FDA.


https://oncolixbio.com

.0015

ONCX Here it goes. 115M O/S as of Jan 1st.

ONCX keep an eye on it. .001 x .0011 with big volume for this ticker.

.0012s falling.

ONCX .001 X .0011 Bounce candidate. Hit 52wkl today. Now with record volume.


https://www.stockscores.com/charts/charts/?ticker=Oncx

VCII 600k bid at .017. Low, but it's there.